Article info

Download PDFPDF
Original article
Preferential hyperacuity perimeter in assessing responsiveness to ranibizumab therapy for exudative age-related macular degeneration
  1. Correspondence to Dr Giuseppe Querques, Department of Ophthalmology, University of Paris XII, Centre Hospitalier Intercommunal de Creteil, 40 Avenue de Verdun, 94000 Creteil, France; giuseppe.querques{at}hotmail.it
View Full Text

Citation

Querques G, Berboucha E, Leveziel N, et al
Preferential hyperacuity perimeter in assessing responsiveness to ranibizumab therapy for exudative age-related macular degeneration

Publication history

  • Accepted November 16, 2010
  • First published December 22, 2010.
Online issue publication 
June 16, 2011

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.